In NCT03294954, GD2-CAR-iNKTs are infused with etanercept, an anti-TNF antibody, based on the observation that TNF promoted tumor progression while inhibition of TNF signaling improved outcomes in murine xenograft models of neuroblastoma (132). The gene discussed is TNF; the disease is neoplasm.